Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking metoclopramide alongside Mounjaro raises a practical question that your prescriber needs to know about. Metoclopramide speeds gastric emptying; tirzepatide (the active ingredient in Mounjaro) deliberately slows it. Those opposing actions on the gut can interfere with each other, and that interaction matters clinically. Mounjaro is a prescription-only medicine requiring a full clinical assessment before use — it isn't prescribed without a thorough review of everything else you take.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide acts on two gut-hormone receptors (GIP and GLP-1) and one of its key effects is slowing the rate at which the stomach empties food into the small intestine. That delay is clinically useful: it prolongs the feeling of fullness and blunts the sharp rise in blood glucose that normally follows a meal. Metoclopramide does the opposite. Prescribed most often for nausea, gastroparesis or reflux, it blocks dopamine receptors in the gut wall and the brain's chemoreceptor trigger zone, pushing stomach contents through more quickly.
When the two are taken together, metoclopramide is essentially working to undo part of what tirzepatide is trying to achieve. The clinical concern runs in both directions. Faster gastric emptying may reduce how well Mounjaro controls appetite and post-meal glucose. And because tirzepatide's slowing effect changes the environment in which metoclopramide itself is absorbed, the prokinetic's own pharmacokinetics can shift in unpredictable ways. The BNF entry for tirzepatide lists this interaction and flags that co-administration should be approached with caution.
This isn't a reason to panic if you've taken both, it's a reason to tell your prescriber promptly so they can review the picture.
Not automatically. A short course of metoclopramide prescribed by a clinician who knows you're on tirzepatide is a very different situation from taking an old packet from the medicine cabinet without mentioning it. Prescribers weigh the reason for the metoclopramide (a one-day post-operative prescription is different from regular use for chronic gastroparesis) against what's happening with your Mounjaro treatment.
Chronic or long-term use of metoclopramide alongside Mounjaro is harder to justify because the two drugs are working against each other persistently, and because metoclopramide itself carries its own neurological cautions at longer durations. Occasional short-term use, on the other hand, may be manageable with monitoring. Only a prescriber who has your full picture can make that call.
If you're exploring Mounjaro for weight management, you can read more about the treatment on our tirzepatide overview page before starting a consultation.
This is the question our prescribers hear most often in this context. Nausea is the most common side effect of tirzepatide, particularly in the first few weeks at a new dose. It's tempting to reach for an anti-emetic, and metoclopramide is freely available on prescription for exactly that reason. But it is not the first-line choice here precisely because of the interaction described above.
The NHS tirzepatide patient guide suggests managing early nausea with smaller meals, eating slowly, avoiding rich or fatty foods, and staying well hydrated. If those adjustments don't help, a prescriber might consider an anti-emetic with a different mechanism (one that doesn't interfere with gastric motility) rather than defaulting to metoclopramide. Domperidone, cyclizine and ondansetron each work differently; the right choice depends on your full medical history, which is why this isn't a decision to make at the pharmacy counter alone.
It's also worth knowing that nausea on tirzepatide usually peaks and fades within days to two weeks of a dose change, and you can find further detail on supportive supplements in our guide to tirzepatide and niacinamide. Many people find that sitting with it briefly, with small dietary adjustments, resolves things without any additional medicine.
Tell your prescriber, today, not at your next planned review. This applies whether you're already on Mounjaro and were prescribed metoclopramide by a GP or another clinician, or whether you take metoclopramide regularly and are considering starting weight-management treatment. Transparency about your medicines list isn't a formality; it's what allows a prescriber to protect both the safety and effectiveness of your treatment.
If you're looking at the wider picture of medicines that interact with Mounjaro, the same principle applies to other drugs that alter gut motility or absorption, you can find related information on loperamide and Mounjaro or, for a different class of interaction, on Mounjaro and ramipril. Oral contraceptive users have a specific additional consideration covered in detail on our medicines-and-Mounjaro section.
For anyone considering private treatment, the consultation process at nume is built around exactly this kind of thorough medicines review. A GPhC-registered prescriber reads every consultation personally before anything is prescribed. Once approved, treatment arrives via DPD the next working day in a plain, unbranded box, tracked to your phone. The clinical review doesn't stop at approval; it continues through every repeat order too.
A useful broader context for how weight-loss medicines are assessed in the UK is the NHS England guidance on weight-management injections, which covers safety considerations including medicines interactions. If you have questions about your specific situation, our team is available via our contact page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.